HEADER OXIDOREDUCTASE 29-JUN-06 2HI4 TITLE CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA- TITLE 2 NAPHTHOFLAVONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTOCHROME P450 1A2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 26-514; COMPND 5 SYNONYM: CYPIA2, P450-P3, P3, 450, P450 4; COMPND 6 EC: 1.14.14.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CYP1A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5ALPHA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCWORI KEYWDS CYP1A2, P450 1A2, P450, MONOOXYGENASE, DRUG METABOLIZING ENZYME, KEYWDS 2 ALPHA-NAPHTHOFLAVONE, BENZO(H)FLAVONE, 7, 8-BENZOFLAVONE, KEYWDS 3 OXIDOREDUCTASE, HEME EXPDTA X-RAY DIFFRACTION AUTHOR S.SANSEN,J.K.YANO,R.L.REYNALD,G.S.SCHOCH,C.D.STOUT,E.F.JOHNSON REVDAT 5 30-AUG-23 2HI4 1 REMARK SEQADV LINK REVDAT 4 18-OCT-17 2HI4 1 REMARK REVDAT 3 24-FEB-09 2HI4 1 VERSN REVDAT 2 31-JUL-07 2HI4 1 JRNL REVDAT 1 20-FEB-07 2HI4 0 JRNL AUTH S.SANSEN,J.K.YANO,R.L.REYNALD,G.A.SCHOCH,K.J.GRIFFIN, JRNL AUTH 2 C.D.STOUT,E.F.JOHNSON JRNL TITL ADAPTATIONS FOR THE OXIDATION OF POLYCYCLIC AROMATIC JRNL TITL 2 HYDROCARBONS EXHIBITED BY THE STRUCTURE OF HUMAN P450 1A2. JRNL REF J.BIOL.CHEM. V. 282 14348 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17311915 JRNL DOI 10.1074/JBC.M611692200 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2726889.250 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.1 REMARK 3 NUMBER OF REFLECTIONS : 38022 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1871 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6145 REMARK 3 BIN R VALUE (WORKING SET) : 0.3710 REMARK 3 BIN FREE R VALUE : 0.3830 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 325 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3845 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.73 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 24.99000 REMARK 3 B22 (A**2) : -12.86000 REMARK 3 B33 (A**2) : -12.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.37 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.41 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.019 REMARK 3 BOND ANGLES (DEGREES) : 2.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.260 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.42 REMARK 3 BSOL : 68.45 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : XDICT_HEME_RELAX.PAR REMARK 3 PARAMETER FILE 4 : BHF.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : XDICT_HEME.TOP REMARK 3 TOPOLOGY FILE 4 : BHF.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HI4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038372. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97945 REMARK 200 MONOCHROMATOR : SIDE SCATTERING BENT CUBE-ROOT I REMARK 200 -BEAM SINGLE CRYSTAL; ASYMMETRIC REMARK 200 CUT 4.965 DEGS REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING); REMARK 200 SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HO RIZONTAL REMARK 200 FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41139 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 88.045 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : 0.09200 REMARK 200 FOR THE DATA SET : 4.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.39400 REMARK 200 R SYM FOR SHELL (I) : 0.39400 REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: CYP2A6, PDB ENTRY 1Z10 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, TRIS, AMMONIUM NITRATE, CYMAL REMARK 280 -6 (CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE), C12E8 REMARK 280 (OCTAETHYLENEGLYCOL MONO-N-DODECYL ETHER) , PH 8.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.81500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.41000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 87.91000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.81500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.41000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 87.91000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.81500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 40.41000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 87.91000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.81500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 40.41000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 87.91000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY HAS NOT BEEN DETERMINED BUT THOUGHT REMARK 300 TO BE A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 25 REMARK 465 ALA A 26 REMARK 465 VAL A 27 REMARK 465 LEU A 28 REMARK 465 LYS A 29 REMARK 465 GLY A 30 REMARK 465 LEU A 31 REMARK 465 ARG A 32 REMARK 465 PRO A 33 REMARK 465 ILE A 514 REMARK 465 ASN A 515 REMARK 465 HIS A 516 REMARK 465 HIS A 517 REMARK 465 HIS A 518 REMARK 465 HIS A 519 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 243 NE - CZ - NH1 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG A 243 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 LEU A 382 CA - CB - CG ANGL. DEV. = -18.1 DEGREES REMARK 500 ARG A 392 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG A 456 NE - CZ - NH2 ANGL. DEV. = -5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 50 -48.38 71.10 REMARK 500 VAL A 99 -66.61 -107.33 REMARK 500 THR A 118 -114.17 41.20 REMARK 500 SER A 129 24.28 -145.05 REMARK 500 SER A 148 -78.66 -138.94 REMARK 500 SER A 157 -14.89 -151.68 REMARK 500 ALA A 230 58.29 -91.78 REMARK 500 ASP A 274 64.31 -101.92 REMARK 500 SER A 279 74.96 -151.69 REMARK 500 LEU A 365 58.51 -112.69 REMARK 500 GLU A 422 -85.70 -53.49 REMARK 500 CYS A 458 125.60 -38.06 REMARK 500 ARG A 511 -176.26 -69.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 900 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 458 SG REMARK 620 2 HEM A 900 NA 105.2 REMARK 620 3 HEM A 900 NB 93.6 91.6 REMARK 620 4 HEM A 900 NC 88.7 165.7 84.2 REMARK 620 5 HEM A 900 ND 106.1 85.3 160.2 93.9 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BHF A 800 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Z10 RELATED DB: PDB REMARK 900 HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND, USED AS MR SEARCH REMARK 900 PROBE REMARK 900 RELATED ID: 1PQ2 RELATED DB: PDB REMARK 900 HUMAN DRUG METABOLIZING FAMILY 2 P450 2C8 REMARK 900 RELATED ID: 1R90 RELATED DB: PDB REMARK 900 HUMAN DRUG METABOLIZING FAMILY 2 P450 2C9 REMARK 900 RELATED ID: 1TQN RELATED DB: PDB REMARK 900 HUMAN DRUG METABOLIZING FAMILY 3 P450 3A4 DBREF 2HI4 A 27 515 UNP P05177 CP1A2_HUMAN 26 514 SEQADV 2HI4 MET A 25 UNP P05177 CLONING ARTIFACT SEQADV 2HI4 ALA A 26 UNP P05177 CLONING ARTIFACT SEQADV 2HI4 HIS A 516 UNP P05177 EXPRESSION TAG SEQADV 2HI4 HIS A 517 UNP P05177 EXPRESSION TAG SEQADV 2HI4 HIS A 518 UNP P05177 EXPRESSION TAG SEQADV 2HI4 HIS A 519 UNP P05177 EXPRESSION TAG SEQRES 1 A 495 MET ALA VAL LEU LYS GLY LEU ARG PRO ARG VAL PRO LYS SEQRES 2 A 495 GLY LEU LYS SER PRO PRO GLU PRO TRP GLY TRP PRO LEU SEQRES 3 A 495 LEU GLY HIS VAL LEU THR LEU GLY LYS ASN PRO HIS LEU SEQRES 4 A 495 ALA LEU SER ARG MET SER GLN ARG TYR GLY ASP VAL LEU SEQRES 5 A 495 GLN ILE ARG ILE GLY SER THR PRO VAL LEU VAL LEU SER SEQRES 6 A 495 ARG LEU ASP THR ILE ARG GLN ALA LEU VAL ARG GLN GLY SEQRES 7 A 495 ASP ASP PHE LYS GLY ARG PRO ASP LEU TYR THR SER THR SEQRES 8 A 495 LEU ILE THR ASP GLY GLN SER LEU THR PHE SER THR ASP SEQRES 9 A 495 SER GLY PRO VAL TRP ALA ALA ARG ARG ARG LEU ALA GLN SEQRES 10 A 495 ASN ALA LEU ASN THR PHE SER ILE ALA SER ASP PRO ALA SEQRES 11 A 495 SER SER SER SER CYS TYR LEU GLU GLU HIS VAL SER LYS SEQRES 12 A 495 GLU ALA LYS ALA LEU ILE SER ARG LEU GLN GLU LEU MET SEQRES 13 A 495 ALA GLY PRO GLY HIS PHE ASP PRO TYR ASN GLN VAL VAL SEQRES 14 A 495 VAL SER VAL ALA ASN VAL ILE GLY ALA MET CYS PHE GLY SEQRES 15 A 495 GLN HIS PHE PRO GLU SER SER ASP GLU MET LEU SER LEU SEQRES 16 A 495 VAL LYS ASN THR HIS GLU PHE VAL GLU THR ALA SER SER SEQRES 17 A 495 GLY ASN PRO LEU ASP PHE PHE PRO ILE LEU ARG TYR LEU SEQRES 18 A 495 PRO ASN PRO ALA LEU GLN ARG PHE LYS ALA PHE ASN GLN SEQRES 19 A 495 ARG PHE LEU TRP PHE LEU GLN LYS THR VAL GLN GLU HIS SEQRES 20 A 495 TYR GLN ASP PHE ASP LYS ASN SER VAL ARG ASP ILE THR SEQRES 21 A 495 GLY ALA LEU PHE LYS HIS SER LYS LYS GLY PRO ARG ALA SEQRES 22 A 495 SER GLY ASN LEU ILE PRO GLN GLU LYS ILE VAL ASN LEU SEQRES 23 A 495 VAL ASN ASP ILE PHE GLY ALA GLY PHE ASP THR VAL THR SEQRES 24 A 495 THR ALA ILE SER TRP SER LEU MET TYR LEU VAL THR LYS SEQRES 25 A 495 PRO GLU ILE GLN ARG LYS ILE GLN LYS GLU LEU ASP THR SEQRES 26 A 495 VAL ILE GLY ARG GLU ARG ARG PRO ARG LEU SER ASP ARG SEQRES 27 A 495 PRO GLN LEU PRO TYR LEU GLU ALA PHE ILE LEU GLU THR SEQRES 28 A 495 PHE ARG HIS SER SER PHE LEU PRO PHE THR ILE PRO HIS SEQRES 29 A 495 SER THR THR ARG ASP THR THR LEU ASN GLY PHE TYR ILE SEQRES 30 A 495 PRO LYS LYS CYS CYS VAL PHE VAL ASN GLN TRP GLN VAL SEQRES 31 A 495 ASN HIS ASP PRO GLU LEU TRP GLU ASP PRO SER GLU PHE SEQRES 32 A 495 ARG PRO GLU ARG PHE LEU THR ALA ASP GLY THR ALA ILE SEQRES 33 A 495 ASN LYS PRO LEU SER GLU LYS MET MET LEU PHE GLY MET SEQRES 34 A 495 GLY LYS ARG ARG CYS ILE GLY GLU VAL LEU ALA LYS TRP SEQRES 35 A 495 GLU ILE PHE LEU PHE LEU ALA ILE LEU LEU GLN GLN LEU SEQRES 36 A 495 GLU PHE SER VAL PRO PRO GLY VAL LYS VAL ASP LEU THR SEQRES 37 A 495 PRO ILE TYR GLY LEU THR MET LYS HIS ALA ARG CYS GLU SEQRES 38 A 495 HIS VAL GLN ALA ARG ARG PHE SER ILE ASN HIS HIS HIS SEQRES 39 A 495 HIS HET HEM A 900 43 HET BHF A 800 21 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM BHF 2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE HETSYN HEM HEME HETSYN BHF 7,8-BENZOFLAVONE; ALPHA-NAPHTHOFLAVONE FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 BHF C19 H12 O2 FORMUL 4 HOH *160(H2 O) HELIX 1 1 HIS A 53 GLY A 58 1 6 HELIX 2 2 ASN A 60 GLY A 73 1 14 HELIX 3 3 ARG A 90 VAL A 99 1 10 HELIX 4 4 GLN A 101 PHE A 105 5 5 HELIX 5 5 LEU A 111 LEU A 116 1 6 HELIX 6 6 GLY A 130 PHE A 147 1 18 HELIX 7 7 CYS A 159 GLY A 182 1 24 HELIX 8 8 ASP A 187 GLY A 206 1 20 HELIX 9 9 GLN A 207 PHE A 209 5 3 HELIX 10 10 SER A 213 LYS A 221 1 9 HELIX 11 11 THR A 223 GLU A 228 1 6 HELIX 12 12 ASN A 234 PHE A 238 5 5 HELIX 13 13 PHE A 239 LEU A 245 5 7 HELIX 14 14 ASN A 247 ASP A 274 1 28 HELIX 15 15 ASP A 282 GLY A 294 1 13 HELIX 16 16 GLN A 304 ASN A 309 1 6 HELIX 17 17 ASN A 309 LYS A 336 1 28 HELIX 18 18 LYS A 336 ILE A 351 1 16 HELIX 19 19 ARG A 358 ARG A 362 5 5 HELIX 20 20 LEU A 365 SER A 380 1 16 HELIX 21 21 ASN A 410 ASP A 417 1 8 HELIX 22 22 ARG A 428 LEU A 433 5 6 HELIX 23 23 ASN A 441 GLU A 446 1 6 HELIX 24 24 MET A 453 ARG A 457 5 5 HELIX 25 25 GLY A 460 LEU A 479 1 20 SHEET 1 A 4 VAL A 75 ILE A 80 0 SHEET 2 A 4 THR A 83 LEU A 88 -1 O VAL A 87 N LEU A 76 SHEET 3 A 4 CYS A 406 VAL A 409 1 O CYS A 406 N LEU A 86 SHEET 4 A 4 HIS A 388 SER A 389 -1 N HIS A 388 O VAL A 407 SHEET 1 B 2 ARG A 296 ALA A 297 0 SHEET 2 B 2 ASN A 300 LEU A 301 -1 O ASN A 300 N ALA A 297 SHEET 1 C 2 THR A 394 LEU A 396 0 SHEET 2 C 2 PHE A 399 ILE A 401 -1 O ILE A 401 N THR A 394 SHEET 1 D 2 GLU A 480 SER A 482 0 SHEET 2 D 2 GLN A 508 ARG A 510 -1 O GLN A 508 N SER A 482 LINK SG CYS A 458 FE HEM A 900 1555 1555 2.35 SITE 1 AC1 23 ARG A 108 THR A 124 TRP A 133 ARG A 137 SITE 2 AC1 23 LEU A 144 ILE A 314 ALA A 317 GLY A 318 SITE 3 AC1 23 THR A 321 PHE A 376 PHE A 381 LEU A 382 SITE 4 AC1 23 THR A 385 ILE A 386 HIS A 388 GLN A 411 SITE 5 AC1 23 LEU A 450 PHE A 451 ARG A 456 CYS A 458 SITE 6 AC1 23 ILE A 459 ALA A 464 HOH A 694 SITE 1 AC2 10 THR A 118 PHE A 226 PHE A 260 ASP A 313 SITE 2 AC2 10 GLY A 316 ALA A 317 ASP A 320 THR A 321 SITE 3 AC2 10 LEU A 497 HOH A 733 CRYST1 79.630 80.820 175.820 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012558 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012373 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005688 0.00000